Edgewise Therapeutics, Inc. (EWTX) Technical Analysis & Indicators
Edgewise Therapeutics, Inc. (EWTX) — Price $38.87 (closing price, November 5, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of Edgewise Therapeutics, Inc. (EWTX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial.